TNYA logo

Tenaya Therapeutics (TNYA)

Profile

Full Name

Tenaya Therapeutics, Inc.

Ticker Symbol

TNYA

Exchange

NASDAQ

Country

United States

IPO

July 30, 2021

Indexes

Not included

Employees

97

Key Details

Price

$0.45(-2.60%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.31(+22.02% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 31, 25 HC Wainwright & Co.
Buy
Mar 13, 25 Canaccord Genuity
Buy
Mar 12, 25 Morgan Stanley
Overweight
Mar 12, 25 Chardan Capital
Buy
Mar 11, 25 HC Wainwright & Co.
Buy
Feb 3, 25 HC Wainwright & Co.
Buy
Jan 14, 25 HC Wainwright & Co.
Buy
Dec 18, 24 HC Wainwright & Co.
Buy
Dec 18, 24 Chardan Capital
Buy
Nov 26, 24 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Tenaya Therapeutics?
  • Does Tenaya Therapeutics pay dividends?
  • What sector is Tenaya Therapeutics in?
  • What industry is Tenaya Therapeutics in?
  • What country is Tenaya Therapeutics based in?
  • When did Tenaya Therapeutics go public?
  • Is Tenaya Therapeutics in the S&P 500?
  • Is Tenaya Therapeutics in the NASDAQ 100?
  • Is Tenaya Therapeutics in the Dow Jones?
  • When was Tenaya Therapeutics's last earnings report?
  • When does Tenaya Therapeutics report earnings?
  • Should I buy Tenaya Therapeutics stock now?

What is the ticker symbol for Tenaya Therapeutics?

The ticker symbol for Tenaya Therapeutics is NASDAQ:TNYA

Does Tenaya Therapeutics pay dividends?

No, Tenaya Therapeutics does not pay dividends

What sector is Tenaya Therapeutics in?

Tenaya Therapeutics is in the Healthcare sector

What industry is Tenaya Therapeutics in?

Tenaya Therapeutics is in the Biotechnology industry

What country is Tenaya Therapeutics based in?

Tenaya Therapeutics is headquartered in United States

When did Tenaya Therapeutics go public?

Tenaya Therapeutics's initial public offering (IPO) was on July 30, 2021

Is Tenaya Therapeutics in the S&P 500?

No, Tenaya Therapeutics is not included in the S&P 500 index

Is Tenaya Therapeutics in the NASDAQ 100?

No, Tenaya Therapeutics is not included in the NASDAQ 100 index

Is Tenaya Therapeutics in the Dow Jones?

No, Tenaya Therapeutics is not included in the Dow Jones index

When was Tenaya Therapeutics's last earnings report?

Tenaya Therapeutics's most recent earnings report was on Mar 10, 2025

When does Tenaya Therapeutics report earnings?

The next expected earnings date for Tenaya Therapeutics is May 14, 2025

Should I buy Tenaya Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page